NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

The problem isn’t that they don't have intention to make money but it’s rather the data is not compelling enough for reimbursement support. So they will continue to kick the can. Otherwise why wouldn’t a company struggling to raise cash and survive submit evidence by now. It’s been 5+ years since data lock. In fact, it should have been submitted well over an year ago. Also, evident from the fact that MHRA (most loyal and supportive RA towards NWBO) is having a hard time deciding and it’s been 2 years since the application was submitted (really unprecedented).

Just wait until Q1 2026 comes and goes and minions are still building false expectations.

Meanwhile dilution accelerates in 2026 by at least 2X from 2025. And that would not even include funds to run a smallish phase 2 trial!

LP’s financiers are going to have an extended party in 2026 and beyond with 500M plus shares to work with.